Vi. Kaledin et al., ANTITUMOR-ACTIVITY OF FREE AND LIPOSOME-E NCAPSULATED PLAXANT IN A HEMICE WITH HA-1 TUMOR-METASTASES IN THE LIVER/, Eksperimental'naa onkologia, 15(5), 1993, pp. 75-77
Plaxant, a new platinum compound injected intravenously (iv) of mice w
ith HA-1 tumour metastases in the liver in a dose of 360 mg/kg gave ri
se to 35.7 % lethality caused by general toxicity and prolonged the li
fe span of the other mice by 61.9 % as compared to the control. Fracti
onal intraperitoneal administration of free plaxant had no advantages
as compared to iv injection. The same dose of plaxant encapsulated in
liposomes after iv administration caused no lethality but increased th
e life span of mice by 91.5 %.